Market Tracker

04/29 7:51am ET

Galena Biopharma Inc (NASDAQ:GALE)

1.43
Delayed Data
As of Apr 28
 +0.04 / +2.88%
Today’s Change
0.59
Today|||52-Week Range
2.39
-2.72%
Year-to-Date
No recent news for Galena Biopharma Inc.

Today’s Trading

Previous close1.39
Today’s open1.39
Day’s range1.36 - 1.45
Volume1,247,608
Average volume (3 months)2,052,168
Market cap$252.6M
Dividend yield--
Data as of 04/28/2016

Growth & Valuation

Earnings growth (last year)-23.32%
Earnings growth (this year)+39.51%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book16.65

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.62-4.30%
BITIBiotie Therapies Cor...+0.24+0.91%
PRTKParatek Pharmaceutic...-0.38-2.62%
ITEKInotek Pharmaceutica...+0.01+0.11%
Data as of 04/28/2016

Financials

Next reporting dateMay 11, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$59.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
San Ramon, California

Forecasts